REFERENCES
- Ko JW, Sekijima JH, Lee SP. Biliary sludge. Ann Intern Med 1999; 130: 301–311.
- Shaffer EA. Gallbladder sludge: what is its clinical signifi-cance? Curr Gastroenterol Rep 2001; 3: 166–173.
- Shiramatsu K, Hirata K, Yamada T, Kimura H, Someya T, Usuki T, et al. Ceftazidime concentration in gallbladder tissue and excretion in bile. Antimicrob Agents Chemother 1988; 32: 1588–1589.
- Souza E, Hellin T, Rodriguez-Creixems M, Martinez-Bel-tran J, Loza E, Baquero F. Comparison of ceftazidime concen-trations in bile and serum. Antimicrob Agents Chemother 1983; 24: 104–106.
- Ko CW, Lee SP. Gallstone formation. Local factors. Gas-troenterol Clin North Am 1999; 28: 99–115.
- Ozturk A, Kaya M, Zeyrek D, Ozturk N, Kat N, Ziylan Z. Ultrasonographic findings in ceftriaxone associated biliary sludge and pseudolithiasis in children. Acta Radiol 2005; 46: 112–116.
- Bor O, Dinleyici EC, Kebapci M, Aydogdu SD. Ceftriax-one-associated biliary sludge and pseudocholelithiasis during childhood: A prospective study. Pediatrics International 2004; 46: 322–324.
- Araz N, Okan V, Demirci M, Araz M. Pseudolithiasis due to ceftriaxone treatment for meningitis in children: Report of 8 cases. Tohoku J Exp Med 2007; 211: 285–290.
- Petri WA Jr. Penicillins, cephalosporins and other 13-lactam antibiotics. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. USA: McGraw-Hill. 2001: 1189-1218.
- Nathorst-Boos J, Philipson A, Hedman A, Arvisson A. Renal elimination of ceftazidime during pregnancy. Am J Obstet Gynecol 1995; 172: 163–166.
- Verhagen CA, Mattie H, Van Strijen E. The renal clear-ance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion. Br J Clin Pharmac 1994; 37: 193–197.